Table 3.
Multivariable prognostic models.
| 3-month follow-up |
12-month follow-up |
|||
|---|---|---|---|---|
| HR [95% CI] | p value | HR [95% CI] | p value | |
| Model 1 | ||||
| Ascites MFAP4 (U/L) | 0.97 [0.93–1.01] | 0.14 | 0.97 [0.94–1.00] | 0.03 |
| MELD-Na | 1.12 [1.04–1.20] | <0.01 | 1.08 [1.02–1.15] | 0.01 |
| Model 2 | ||||
| Ascites MFAP4 (U/L) | 0.97 [0.93-1.00] | 0.11 | 0.96 [0.93–0.99] | 0.02 |
| CLIF-C AD | 1.07 [1.02–1.13] | 0.01 | 1.05 [1.00–1.09] | 0.03 |
| Model 3 | ||||
| Ascites MFAP4 (U/L) | 0.97 [0.93–1.01] | 0.11 | 0.97 [0.94–1.00] | 0.03 |
| Child-Pugh score | 1.24 [0.93–1.66] | 0.14 | 1.18 [0.94–1.49] | 0.16 |
Values in bold denote statistical significance. Multivariable Cox regression models of transplant-free survival. Three distinct multivariable models were computed. CLIF-C AD, CLIF Consortium Acute Decompensation; HR, hazard ratio; MELD-Na, model for end-stage liver disease; MFAP4, microfibrillar-associated protein 4.